Composite materials that contain formaldehyde-free, cured binder compositions are disclosed. Also disclosed are methods of making and using composite materials containing formaldehyde-free binder compositions.
Anti-Il-12 Antibody Based Vectors, Host Cells, And Methods Of Production And Uses
Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
Anti-Il-12 Antibody Based Vectors, Host Cells, And Methods Of Production And Uses
Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
Cngh0005 Polypeptides, Antibodies, Compositions, Methods And Uses
The present invention relates to at least one novel CNGH0005 polypeptides, antibodies, including isolated nucleic acids that encode at least one CNGH0005 polypeptide or antibody, CNGH0005 vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Engineered Anti-Target Immunoglobulin Derived Proteins, Compositions, Methods And Uses
The present invention relates to anti-target immunoglobulin derived proteins, including isolated nucleic acids that encode at least one anti-target Ig derived protein, target, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Method And Apparatus For Analyzing And Generating Human Antibody Amino Acid And Nucleic Acid Sequences
The invention provides methods, computer programs, data and databases, computer readable media, computer systems, and/or apparatus that use, compare or generate data corresponding to at least one partial antibody or antibody fusion protein nucleic acid or amino acid sequence, on recordable media or in computer memory, such as engineered antibody or antibody fusion protein sequences that include any combination of partial antibody sequences, as well as comparisons between different human antibody partial or full sequences, wherein the present invention can be used, inter alia, for research, diagnostic and/or therapeutic products, methods and devices.
Design And Generation Of Human De Novo Pix Phage Display Libraries
Ping Tsui - Berwyn PA, US Lei Shi - Radnor PA, US Jin Lu - Radnor PA, US John Wheeler - Radnor PA, US Brian Whitaker - Radnor PA, US Lionella Borozdina-Birch - San Diego CA, US Juan C. Almagro - Radnor PA, US Bernard Amegadzie - Radnor PA, US Mark Tornetta - Radnor PA, US Ramachandra Reddy - Radnor PA, US David M. Knight - Radnor PA, US Jinquan Luo - Radnor PA, US Raymond W. Sweet - Radnor PA, US Qiang Chen - San Diego CA, US
Described and claimed herein are combinatorial synthetic Fab libraries displayed on a phage pIX protein. The libraries were built on scaffolds representing the most frequently used genes in human antibodies, which were diversified to mirror the variability of natural antibodies. After selection using a diverse panel of proteins, numerous specific and high-affinity Fabs were isolated. By a process called in-line maturation the affinity of some antibodies was improved up to one hundred-fold yielding low pM binders suitable for in vivo use. This work thus demonstrates the feasibility of displaying complex Fab libraries as pIX-fusion proteins for antibody discovery and lays the foundations for studies on the structure-function relationship of antibodies.
Vectors, Host Cells, And Methods Of Production And Uses
Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids.
Incyte
Director
Incyte
Associate Director
Johnson & Johnson Jan 2002 - Apr 2015
Principal Scientist
Centocor 2008 - 2010
Head of Informatics For Biologics Coe
Centocor May 2005 - May 2008
Principal Research Scientist
Education:
Shanghai Jiao Tong University
Bachelors, Bachelor of Science, Biomedical Engineering, Medicine
The University of Texas Medical Branch
Doctorates, Doctor of Philosophy, Physiology, Neuroscience
Villanova University
Master of Science, Masters, Applied Statistics
Skills:
Bioinformatics Biomarker Discovery Drug Discovery Protein Chemistry Antibodies Drug Development Immunology Proteomics Dna Sequencing Sequence Analysis Assay Development Flow Cytometry Oncology Biomarkers Genomics Microarray Cell In Vitro Translational Research High Throughput Screening Systems Biology Monoclonal Antibodies Certified Project Manage Professional Informatics Translational Medicine Cell Biology Lims
Arkema Jun 2016 - Jul 2017
Manager, Business Development
Arkema Jun 2016 - Jul 2017
Senior Research Scientist
Arkema Sartomer Business Group 2011 - 2016
Manager, Adhesives, Sealants and Personal Care R and D Platforms; Global Asp Technical Leader
Sartomer Jul 2006 - Jul 2011
Technical Leader, Oligomer Group
Trillion Science Jan 2006 - Jun 2006
Senior Technical Manager
Education:
Drexel University's Lebow College of Business 2011 - 2013
Master of Business Administration, Masters, Finance
University of Pennsylvania 2001 - 2002
North Carolina State University 1997 - 2001
Doctorates, Doctor of Philosophy
Institute of Chmistry, the Chinese Academy of Sciences 1994 - 1997
Master of Science, Masters, Physics
Tongji University 1989 - 1994
Bachelors, Bachelor of Science, Materials Science, Engineering
Skills:
Polymers Coatings Chemistry Adhesives Product Development R&D Commercialization Spectroscopy Polymer Science Cross Functional Team Leadership Strategy Raw Materials Manufacturing Polyurethane Materials Science Materials Plastics Research and Development Chemical Engineering New Markets Development Polymer Chemistry Strategic Planning Business Development